ArticleJournal of molecular medicine (Berlin, Germany)2005

An oncolytic adenovirus controlled by a modified telomerase promoter is attenuated in telomerase-negative cells, but shows reduced activity in cancer cells.

S Bortolanza et al.PubMed ↗Publisher ↗

No numbers read from the abstract.